Tenet Healthcare Corp

THCNYSE

$292.97

2.700.93%

Ult. Agg.: Nov 11, 4:20 PM

Panoramica Notizie Grafici Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Tenet Healthcare (THC) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Tenet Healthcare (THC) stock.

Analyst Consensus — 20 Analysts

18Buy

2Hold

# Analysts20

Latest Upgrades and Downgrades for Tenet Healthcare Stock

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Barclays	Andrew Mok	PT Raise	Overweight	$271→$297
—	Truist Securities	David Macdonald	PT Raise	Buy	$290→$305
—	Keybanc	Matthew Gillmor	PT Raise	Overweight	$270→$300
—	Leerink Partners	Whit Mayo	PT Raise	Outperform	$309→$342
—	RBC Capital	Ben Hendrix	PT Raise	Outperform	$283→$304
—	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$281→$321
—	Guggenheim	Jason Cassorla	PT Cut	Buy	$307→$306
—	Guggenheim	Jason Cassorla	PT Raise	Buy	$283→$307
—	BMO Capital	Sean Dodge	Initiate	Market Perform	$265
—	Leerink Partners	Whit Mayo	Maintained	Outperform	$309
—	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$231→$281
—	Truist Securities	David Macdonald	PT Raise	Buy	$270→$290
—	Baird	Michael Ha	PT Raise	Neutral	$210→$280
—	Guggenheim	Jason Cassorla	PT Raise	Buy	$242→$283
—	UBS	A.J. Rice	PT Raise	Buy	$288→$308
—	TD Cowen	Ryan Langston	PT Raise	Buy	$233→$263
—	Morgan Stanley	Craig Hettenbach	PT Raise	Overweight	$254→$274
—	RBC Capital	Ben Hendrix	PT Raise	Outperform	$236→$283
—	Barclays	Andrew Mok	PT Raise	Overweight	$240→$271
—	Guggenheim	Jason Cassorla	PT Cut	Buy	$252→$242

Tenet Healthcare Corp

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Tenet Healthcare (THC) Stock Price Target 2026

Latest Upgrades and Downgrades for Tenet Healthcare Stock

Tenet Healthcare (THC) Stock Price Target 2026

Latest Upgrades and Downgrades for Tenet Healthcare Stock

Analyst Ratings News

PRO
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297

PRO
Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

PRO
Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

PRO
Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

PRO
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297

PRO
Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

PRO
Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

PRO
Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

PRO
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321

Tenet Healthcare Corp

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Tenet Healthcare (THC) Stock Price Target 2026

Latest Upgrades and Downgrades for Tenet Healthcare Stock

Tenet Healthcare (THC) Stock Price Target 2026

Latest Upgrades and Downgrades for Tenet Healthcare Stock

Analyst Ratings News

PROBarclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297

PROTruist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

PROKeybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

PROLeerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

PRORBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

PROWells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321

People Also Watch

People Also Watch

Analyst Ratings News

PROBarclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297

PROTruist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

PROKeybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

PROLeerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

PRORBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

PROWells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321

PRO
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297

PRO
Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

PRO
Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

PRO
Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

PRO
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321

PRO
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297

PRO
Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305

PRO
Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300

PRO
Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

PRO
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321